Contract Service Directory

Velesco Pharmaceutical Services





Company Headquarters

28036 Oakland Oaks Court
Wixom, MI 48393
United States

Company Description

Velesco Pharma brings expertise to 1. Formulation of novel solutions for non-clinical and clinical formulations, 2. Analytical methods developed by a team with proven problem solving capabilities, and 3. Early phase cGMP Clinical Trial Materials with capabilities across non-sterile dosage forms. Velesco offers personalized project management and expert advice to ensure the best chance of success in clinical trials. We collaborate with clients developing a customized plan to efficiently bring compounds through preclinical development into the clinic.

Contract Service Directory

    Related Content

    • Breaking News | cGMP Manufacture | Clinical Trial Materials | GMPs/GCPs | Industry News
      CureVac Granted Mfg. Authorization for GMP Production Suite

      CureVac Granted Mfg. Authorization for GMP Production Suite

      GMP Production Suite scales up capacity for preclinical, clinical and early launch needs for proprietary and partnered programs
      12.03.19

    • Breaking News | Promotions & Moves
      Agios Pharmaceuticals Appoints CSO

      Agios Pharmaceuticals Appoints CSO

      Dr. Car spent 25 years at Bristol-Myers Squibb and its legacy companies
      12.02.19

    • AAPS Exhibitor List

      Company Name Booth # 3D BIOOPTIMA CO., LTD. 1205 AbbVie 2639 AbbVie C1 ABITEC CORPORATION 628 Absorption Systems…
      10.29.19


    • Breaking News | Industry News | Inspections | Regulatory Affairs
      Almac Completes Three Regulatory Inspections

      Almac Completes Three Regulatory Inspections

      Inspections at Charnwood, Craigavon, and Audubon sites successful
      09.27.19

    • Drug Development
      Flex Your Outsourcing Model to Maximize Drug Development

      Flex Your Outsourcing Model to Maximize Drug Development

      How to choose—and optimize—combinations of service models to fit your needs.
      Timothy King, Executive Director, Functional Service Partnerships (FSP), PPD 09.16.19

    • Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
      Catalent, Acura Enter Clinical Manufacturing Pact

      Catalent, Acura Enter Clinical Manufacturing Pact

      Catalent to scale-up manufacturing of LTX-03 for clinical testing
      09.16.19


    • Breaking News | Clinical Trial Materials | Facilities | Industry News | Packaging & Tracking
      Sharp’s Netherlands Facility Approved for Clinical Operations

      Sharp’s Netherlands Facility Approved for Clinical Operations

      Will be ready to receive clinical material from September 2019
      09.12.19

    • Biologics, Proteins, Vaccines | Drug Delivery | Injectables
      Growth in Biologics and Maintaining Patient Satisfaction

      Growth in Biologics and Maintaining Patient Satisfaction

      Vicki A. Barbur of Battelle discusses the driving forces for biologics, the challenges, and new delivery methods
      Kristin Brooks, Contrct Pharma 08.09.19

    • Breaking News | Facilities | Industry News
      Vetio Completes Plant Expansion in Montreal

      Vetio Completes Plant Expansion in Montreal

      Facility produces liquids, semi-solids, tablets, intermediates and blends
      08.02.19


    • Breaking News | Industry News
      Eurofins Amatsigroup Rebrands to Eurofins CDMO

      Eurofins Amatsigroup Rebrands to Eurofins CDMO

      Provides integrated, end-to-end solutions for pre-clinical and clinical outsourcing services
      07.31.19

    • Trials & Filings
      La Jolla Pharma Receives Orphan Designation for Malaria Treatment

      La Jolla Pharma Receives Orphan Designation for Malaria Treatment

      LJPC-0118, artesunate, demonstrated to be superior to quinine in reducing mortality in patients with falciparum malaria infection
      07.23.19

    • 22	ASTELLAS

      22 ASTELLAS

      Headquarters: Tokyo, Japan twitter.com/AstellasUS www.astellas.com Headcount:    16,243 Year Established: 2005 Revenues:       $11,781 (flat) Net Income:       …
      07.15.19